Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA and Europe (2014–17)

ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries

(2018) Rodrigo E Mendes et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya

(2018) J Michael Miller et al.   CLINICAL INFECTIOUS DISEASES

Osteomyelitis

(2017) Steven K. Schmitt   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

In vitro activity of tedizolid and comparator agents against Gram-positive pathogens responsible for bone and joint infections

(2017) Pauline Ract et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014

(2016) Michael A. Pfaller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic

(2015) Steven D. Burdette et al.   CLINICAL INFECTIOUS DISEASES

Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens

(2015) George G. Zhanel et al.   DRUGS

Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections

(2014) Andrew F. Shorr et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prosthetic Joint Infection

(2014) A. J. Tande et al.   CLINICAL MICROBIOLOGY REVIEWS

Epidemiology and burden of prosthetic joint infections

(2014) T. Lamagni   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Tedizolid for the Management of Human Infections: In Vitro Characteristics

(2013) Jeffrey B. Locke et al.   CLINICAL INFECTIOUS DISEASES

Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections

(2013) Philippe Prokocimer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

In VitroActivity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections

(2012) Philippe Prokocimer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America

(2012) D. R. Osmon et al.   CLINICAL INFECTIOUS DISEASES